🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: be.science
Article #451

Cancer - Press Review (December 22, 2012) – Revue de presse (22 décembre 2012)

#451
From: SMW
Date: Sun, 23 Dec 2012 16:56
125 lines
7332 bytes
Press Review (December 22, 2012) – Revue de presse (22 décembre 2012)

Game changing diagnostic & prognostic prostate cancer genetic tests
revealed by Jefferson
Researchers at the Kimmel Cancer Center at Jefferson have developed
potentially game-changing diagnostic and prognostic genetic tests
shown to better predict prostate cancer survival outcomes and
distinguish clinically-relevant cancers.
In EurekAlert (press release)
http://www.eurekalert.org/pub_releases/2012-12/tju-gcd122012.php

Scientists Engineer Algae To Produce New Targeted Cancer Therapy
Next-generation cancer therapies are notoriously expensive. But maybe
not for long.
By Emily Elert. In Popular Science
http://www.popsci.com/science/article/2012-12/scientists-engineer-algae-produce-new-targeted-cancer-therapy

Cancer breakthrough: Disease depends on surrounding normal cells to
spread, study finds
In a major breakthrough, Toronto scientists have discovered a new
approach to cancer treatment that would target the “normal” cells
embedded around tumours.
By Joseph Hall. In Toronto Star
http://www.thestar.com/news/gta/article/1305033--cancer-breakthrough-disease-depends-on-surrounding-normal-cells-to-spread-study-finds

Breast cancer photo projects on show at UAB Visual Arts Gallery
The University of Alabama at Birmingham (UAB) Visual Arts Gallery will
present two powerful photographic projects on young women and breast
cancer by fashion photographer David Jay Jan. 7-31, 2013.
By Shannon Thomason. In UAB News
http://www.uab.edu/news/latest/item/3010-breast-cancer-photo-projects-on-show-at-uab-visual-arts-gallery

Enzyme linked to prostate cancer may help identify lethal form of
disease
Cancer researchers have identified an enzyme specifically linked to
prostate cancer that they believe may help in early detection of an
aggressive and deadly form of the disease.
By Noor Javed. In Toronto Star
http://www.thestar.com/living/article/1304959--enzyme-linked-to-prostate-cancer-may-help-identify-lethal-form-of-disease

MicroRNAs present exciting opportunities for cancer therapy and
diagnosis
MicroRNA molecules potential biomarkers for early cancer detection,
reports cancer biomarkers.
In EurekAlert (press release)
http://www.eurekalert.org/pub_releases/2012-12/ip-mpe121912.php



Coffee Drinking Linked With Lower Oral Cancer Death Risk: Study
As if there weren't already a host of other reasons to love coffee, a
new study links drinking several cups a day with a decreased risk of
dying from oral cancer.
In Huffington Post
http://www.huffingtonpost.com/2012/12/18/coffee-oral-cancer-throat-death_n_2317525.html

Cancer News Blood cell gene fault linked to breast and ovarian cancer
Scientists have linked a rare genetic fault in the immune system to an
increased risk of breast and ovarian cancers.
In Cancer Research UK
http://www.cancerresearchuk.org/cancer-info/news/archive/cancernews/2012-12-17-Blood-cell-gene-fault-linked-to-breast-and-ovarian-cancer

Poison for cancer cells: New method identifies active agents in
mixtures of hundreds of substances
In their quest for new agents, pharmaceutical researchers test
millions of substances all over the world. They like using color-
forming reactions to identify new molecules. However, in intensively
colored solutions or in the case of mixtures with multiple substances
these tests fail. As part of his doctoral thesis, Martin Stein, member
of staff at the Chair of Biochemistry at the Technische Universitaet
Muenchen, developed a testing reaction based on magnetic resonance
data. It helps find a specific pharmaceutical molecule among hundreds
of different substances even in the most turbid of bacterial brews
In Medical XPress
http://medicalxpress.com/news/2012-12-poison-cancer-cells-method-agents.html


Des boules de glace pour soigner le cancer du sein
Les patientes atteintes de cancer du sein pourraient être traitées
sans chirurgie grâce au développement d'une technique qui détruit les
tumeurs en les gelant.
Dans JOL Press (Blog)
http://www.jolpress.com/sante-cancer-su-sein-boules-de-glace-cryoablation-tumeur-article-815853.html

Le café, un bon anti-cancer
Selon une récente étude américaine, boire régulièrement du café
diminuerait considérablement le risque de développer des cancers de la
bouche ou de la gorge.
Dans Aujourdhui.com
http://sante.aujourdhui.com/info/le-cafe-un-bon-anti-cancer-22139.asp

Cancer : les cellules tumorales ne supportent pas la pression !
L'allongement de la durée du traitement par tamoxifène en adjuvant à
10 ans permet de réduire le risque de récidive tardive du cancer du
sein avec expression des récepteurs aux estrogènes (ER+) et améliore
la survie, selon l'étude ATLAS (Adjuvant Tamoxifen - Longer Against
Shorter) présentée au San Antonio Breast Cancer Symposium (SABCS) et
publiée simultanément dans le Lancet.
Par Janlou Chaput. Dans Futura-Sciences
http://www.futura-sciences.com/fr/news/t/medecine/d/cancer-les-cellules-tumorales-ne-supportent-pas-la-pression_43486/

Aider les patients sous chimio qui sont « dans le brouillard »
La médecine s'intéresse de plus en plus aux troubles cognitifs qui
touchent temporairement certaines personnes traitées pour un cancer.
Par Pauline Fréour. Dans Le Figaro-Santé
http://sante.lefigaro.fr/actualite/2012/12/18/19596-aider-patients-sous-chimio-qui-sont-dans-brouillard

Cancer : des médicaments fabriqués grâce à des algues
Traditionnellement dédiée à la production de biocarburants, l'algue
microspique Chlamydomonas reinhardtii permet de produire à moindre
coût des protéines complexes utilisées dans le traitement de certains
cancers.
Par Marc Mennessier. Dans Le Figaro-Santé
http://sante.lefigaro.fr/actualite/2012/12/14/19583-cancer-medicaments-fabriques-grace-algues
Technical Details
Message-ID: <4f0503a4-c46c-4d1c-9575-f38119813f53@j4g2000yqh.googlegroups.com>
Path: arc1-ca.pugleaf.net!k2ni2110qap.0!nntp.google.com!ee4no1916798qab.0!postnews.google.com!j4g2000yqh.googlegroups.com!not-for-mail

Show Full Headers
Complete Article Headers
X-Google-Thread: a254ea4a8d,e9237528f7d9dce1,start
X-Google-Attributes: gida254ea4a8d,public,usenet
X-Google-NewGroupId: yes
X-Google-Language: ENGLISH,CP1252
X-Received: by 10.224.190.193 with SMTP id dj1mr9632799qab.6.1356281812976;
        Sun, 23 Dec 2012 08:56:52 -0800 (PST)
MIME-Version: 1.0
Received: by 10.49.87.1 with SMTP id t1mr2736284qez.41.1356281812951; Sun, 23
 Dec 2012 08:56:52 -0800 (PST)
Path: arc1-ca.pugleaf.net!k2ni2110qap.0!nntp.google.com!ee4no1916798qab.0!postnews.google.com!j4g2000yqh.googlegroups.com!not-for-mail
Newsgroups: be.science
Date: Sun, 23 Dec 2012 08:56:52 -0800 (PST)
Complaints-To: groups-abuse@google.com
Injection-Info: j4g2000yqh.googlegroups.com; posting-host=81.247.214.137; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
NNTP-Posting-Host: 81.247.214.137
User-Agent: G2/1.0
X-HTTP-UserAgent: Mozilla/5.0 (Windows NT 5.1) AppleWebKit/537.11 (KHTML, like
 Gecko) Chrome/23.0.1271.97 Safari/537.11,gzip(gfe)
Message-ID: <4f0503a4-c46c-4d1c-9575-f38119813f53@j4g2000yqh.googlegroups.com>
Subject: Cancer - Press Review (December 22, 2012) – Revue de presse (22 décembre 2012)
From: SMW <scimedweb@mail.com>
Injection-Date: Sun, 23 Dec 2012 16:56:52 +0000
Content-Type: text/plain; charset=windows-1252
Content-Transfer-Encoding: quoted-printable